• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/4/21 4:05:25 PM ET
    $VGAC
    Business Services
    Finance
    Get the next $VGAC alert in real time by email
    SC 13G 1 p21-0357sc13g.htm VG ACQUISITION CORP.

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
    (Amendment No.  )*
     

    VG Acquisition Corp.

    (Name of Issuer)
     

    Class A ordinary shares, par value $0.0001 per share

    (Title of Class of Securities)
     

    G9446E105

    (CUSIP Number)
     

    January 25, 2021

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    x Rule 13d-1(b)
    x Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 8 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. G9446E105

    13GPage 2 of 8 Pages

     

    1

    NAME OF REPORTING PERSON

    Marshall Wace LLP

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) x

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    England

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    2,626,787

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    2,626,787

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    2,626,787

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.2%

    12

    TYPE OF REPORTING PERSON

    IA, PN

             

     

     

     

     

     

    CUSIP No. G9446E105

    13GPage 3 of 8 Pages

     

     

    1

    NAME OF REPORTING PERSON

    Marshall Wace Investment Strategies – Eureka Fund

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) x

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Ireland

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    2,241,970*

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    2,241,970*

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    2,241,970*

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    4.4%*

    12

    TYPE OF REPORTING PERSON

    OO

             

     

    * As of the date of event which requires filing of this Schedule 13G, Marshall Wace Investment Strategies – Eureka Fund beneficially owned more than 5% of the outstanding Class A Ordinary Shares.

     

     

    CUSIP No. G9446E105

    13GPage 4 of 8 Pages

     

     

    Item 1(a). NAME OF ISSUER:
       
      The name of the issuer is VG Acquisition Corp., a Cayman Islands corporation (the "Company").

     

    Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
       
      The Company's principal executive offices are located at 65 Bleecker Street, 6th Floor, New York, NY 10012.

     

    Item 2(a). NAME OF PERSON FILING:
       
      This statement is filed by:

     

      (i) Marshall Wace Investment Strategies – Eureka Fund. a segregated sub-trust of an umbrella unit trust established in Ireland (the "Eureka Fund"), with respect to the Class A Ordinary Shares (as defined below) directly held by it; and
         
      (ii) Marshall Wace LLP, a limited liability partnership formed in England (the "Investment Manager"), with respect to the Class A Ordinary Shares directly held by the Eureka Fund and other funds and accounts to which it acts as investment manager.

     

      The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
       
      The Investment Manager acts as investment manager to the Eureka Fund and other funds and accounts.  The Investment Manager has delegated certain authority for US operations and trading to Marshall Wace North America L.P.
       
      The filing of this statement should not be construed as an admission that any of the foregoing persons is, for the purposes of Section 13 of the Act, the beneficial owner of the Class A Ordinary Shares reported herein.

     

    Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
       
      The address of the business office of the Eureka Fund is 32 Molesworth Street, Dublin 2, Ireland; and the address of the business office of the Investment Manager is George House, 131 Sloane Street, London, SW1X 9AT, UK.

     

    Item 2(c). CITIZENSHIP:
       
      The Eureka Fund is a segregated sub-trust of an umbrella unit trust established in Ireland.  The Investment Manager is a limited liability partnership formed in England.

     

    Item 2(d). TITLE OF CLASS OF SECURITIES:
       
      Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares").

     

    CUSIP No. G9446E105

    13GPage 5 of 8 Pages

     

     

    Item 2(e). CUSIP NUMBER:
       
      G9446E105

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) ¨ Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) ¨

    Employee benefit plan or endowment fund in accordance with

    Rule 13d-1(b)(1)(ii)(F);

     

      (g) ¨

    Parent holding company or control person in accordance with

    Rule 13d-1(b)(1)(ii)(G);

      (h) ¨

    Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i) ¨

    Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

      (j) ¨ Non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

      If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please
      specify the type of institution:  

     

    Item 4. OWNERSHIP
       
      The percentages set forth herein are calculated based upon 50,855,000 Class A Ordinary Shares outstanding as of November 16, 2020 as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020, filed with the Securities and Exchange Commission on November 16, 2020.
       
      The information required by Items 4(a) – (c)  is set forth in Rows (5) – (11) of the cover page for each of the Reporting Person hereto and is incorporated herein by reference for each Reporting Person.

     

    CUSIP No. G9446E105

    13GPage 6 of 8 Pages

     

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
       
      As of the date hereof, Marshall Wace Investment Strategies – Eureka Fund has ceased to be the beneficial owner of more than 5% of the outstanding Class A Ordinary Shares.

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
       
      See Item 2(a).

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
       
      Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
       
      Not applicable.

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP.
       
      Not applicable.

     

    Item 10. CERTIFICATION.
       
      Each Reporting Person hereby makes the following certification:
       
      By signing below, each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

    CUSIP No. G9446E105

    13GPage 7 of 8 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of its or his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATE: February 4, 2021

     

    MARSHALL WACE LLP  
       
       
    By: /s/ Jon May  
    Name:  Jon May  
    Title:    General Counsel  
       
         

     

     

    MARSHALL WACE INVESTMENT STRATEGIES – EUREKA FUND  
       
    By: Marshall Wace Ireland Limited, in its capacity
    as manager of the Eureka Fund
     
       
       
    By: /s/ Linburgh Martin  
    Name:  Linburgh Martin  
    Title:    Director  
       
         

     

    CUSIP No. G9446E105

    13GPage 8 of 8 Pages

    EXHIBIT 1

    JOINT ACQUISITION STATEMENT
    PURSUANT TO RULE 13d-1(k)

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

    DATED: February 4, 2021

     

    MARSHALL WACE LLP  
       
       
    By: /s/ Jon May  
    Name:  Jon May  
    Title:    General Counsel  
       
         

     

     

    MARSHALL WACE INVESTMENT STRATEGIES – EUREKA FUND  
       
    By: Marshall Wace Ireland Limited, in its capacity
    as manager of the Eureka Fund
     
       
       
    By: /s/ Linburgh Martin  
    Name:  Linburgh Martin  
    Title:    Director  
       
         

     

    Get the next $VGAC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VGAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $VGAC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hercules Capital Reports Second Quarter 2021 Financial Results

      Record Year-to-Date Total Debt and Equity Commitments of $971.7 Million Record Year-to-Date Total Fundings of $634.0 Million Surpassed $12.0 Billion in Cumulative Total Debt Commitments since Inception Q2 2021 Net Asset Value per Share Increased 3.1% to $11.71 from Q1 2021 Record Undistributed Earnings Spillover of $160.2 Million, or $1.38(1) per Ending Shares Outstanding Q2 2021 Financial Achievements and Highlights Net Investment Income "NII" of $37.0 million, or $0.32 per share, an increase of 3.6% year-over-year Total Investment Income of $69.6 million, an increase of 2.3% year-over-year Total gross new debt and equity commitments of $440.8 million Net Hercules' debt and e

      7/29/21 4:10:00 PM ET
      $ZETA
      $IPSC
      $HCXY
      $XMTR
      Computer Software: Prepackaged Software
      Technology
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • 23andMe Successfully Closes its Business Combination with VG Acquisition Corp.

      SUNNYVALE, Calif. and NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- 23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE:VGAC), a special purpose acquisition company sponsored by Virgin Group, today announced the completion of their previously announced business combination. The transaction, which was approved on June 10, 2021 by VG Acquisition Corp.'s shareholders, uniquely positions 23andMe to revolutionize personalized healthcare and therapeutic development through human genetics. The combined company is called 23andMe Holding Co. and will be traded on The Nasdaq Global Select Market ("Nasdaq") beginning on June 17, 2021 under the new ticker symb

      6/16/21 5:29:17 PM ET
      $VGAC
      Business Services
      Finance
    • Virgin Group's VG Acquisition Corp. Shareholders Approve Business Combination with 23andMe, Inc.

      NEW YORK, June 10, 2021 /PRNewswire/ -- VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group ("VGAC" or the "Company") today announced that its shareholders voted to approve the previously announced merger agreement with 23andMe, Inc. ("23andMe") at VGAC's extraordinary general meeting of shareholders (the "Special Meeting") held earlier today. More than 87% of the votes cast at the Special Meeting were in favor of the approval of the merger agreement.  VGAC shareholders also voted overwhelmingly to approve the other proposals presented at the Special Meeting. As previously announced, the consummation of the business combination with 23andMe is

      6/10/21 4:33:00 PM ET
      $VGAC
      Business Services
      Finance

    $VGAC
    SEC Filings

    See more
    • SEC Form S-1 filed by VG Acquisition Corp.

      S-1 - 23andMe Holding Co. (0001804591) (Filer)

      7/8/21 4:42:12 PM ET
      $VGAC
      Business Services
      Finance
    • VG Acquisition Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Changes in Registrant’s Certifying Accountant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (Amendment)

      8-K/A - 23andMe Holding Co. (0001804591) (Filer)

      6/21/21 8:32:07 AM ET
      $VGAC
      Business Services
      Finance
    • VG Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status

      8-K - 23andMe Holding Co. (0001804591) (Filer)

      6/21/21 8:31:01 AM ET
      $VGAC
      Business Services
      Finance

    $VGAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by Chung Patrick S

      3 - 23andMe Holding Co. (0001804591) (Issuer)

      7/2/21 6:25:41 PM ET
      $VGAC
      Business Services
      Finance
    • SEC Form 3 filed by MONTGOMERY RICE VALERIE MD

      3 - 23andMe Holding Co. (0001804591) (Issuer)

      6/25/21 5:36:27 PM ET
      $VGAC
      Business Services
      Finance
    • SEC Form 3 filed by BOTHA ROELOF

      3 - 23andMe Holding Co. (0001804591) (Issuer)

      6/25/21 5:35:39 PM ET
      $VGAC
      Business Services
      Finance

    $VGAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by VG Acquisition Corp.

      SC 13G - 23andMe Holding Co. (0001804591) (Subject)

      6/30/21 5:21:03 PM ET
      $VGAC
      Business Services
      Finance
    • SEC Form SC 13D filed by VG Acquisition Corp.

      SC 13D - 23andMe Holding Co. (0001804591) (Subject)

      6/25/21 5:16:06 PM ET
      $VGAC
      Business Services
      Finance
    • SEC Form SC 13G filed by VG Acquisition Corp.

      SC 13G - VG Acquisition Corp. (0001804591) (Subject)

      4/26/21 4:33:18 PM ET
      $VGAC
      Business Services
      Finance